Su Dong of Pan to Yaoxin Pharmaceutical Group. The four people here naturally know that a little-known small pharmaceutical factory in Yuanzhou, although it has been injected by Xinlan Investment Group of the United States, but under the control of this Su Dong, after a few years of exhibition, it actually won the Linjing Pharmaceutical Group, which is at least one of the top five old large enterprises in China, at the beginning of this year, and formed an absolute controlling stake, so as to determine the industry leading position of Tianxin Pharmaceutical Group in one fell swoop. Already close to legendary. What's even more legendary is that this Su Dong is only in his twenties this year. And those who have seen her say that she is beautiful. has an excellent demeanor, if you don't know its identity, you must think it is a film and television star. But in fact. People who are more familiar with her are extremely disdainful of this statement, what film and television star has the quiet and indifferent, natural and elegant temperament of Su Dong? The person who said that Su Dong was like a movie star was just that he didn't have any taste and taste.

As of Linjing Pharmaceutical Group, in the short period of four or five years of Tianxin Pharmaceutical Group, 6 large pharmaceutical groups and companies have been annexed by it, and a medium-sized beverage factory and a packaging company have been acquired, and it has also established and is establishing medicinal material production bases in 17 regions across the country, and the scope of radiation is no longer limited to a corner or even a certain region such as the south and the north. Today's Tianxin Pharmaceutical Group is worthy of the name to create a national marketing network, and its products cover all parts of the country. It can be said that Tianxin Pharmaceutical Group can be found in any city in the country

Product.

Many people once wondered how Tianxin Pharmaceutical Group had such a rich capital, and whether there was a possibility of tax evasion due to the accumulation of these capitals, after all, judging from the annual financial reports of Tianxin Pharmaceutical Factory, the predecessor of Tianxin Pharmaceutical Group, although its revenue capacity was considerable, it was absolutely impossible to support such a large-scale expansion.

But the results have taken many by surprise. Tianxin Pharmaceutical Group seems to have expected that there will be a huge financial war in Southeast Asia before the Asian financial crisis, and it is to take the free ride of financial predators such as Soros, and carry out an unrelenting blow to foreign currencies such as Thailand, and it is initially estimated that Tianxin Pharmaceutical Group, which originally had total assets of about Yi Yuan, has harvested at least 50 to 80 billion yuan through financial warfare during this period of time, and has received the fifth capital injection of Xinlan Group of the United States again. From a small pharmaceutical factory with a capital of several million yuan to a butterfly, it has become a giant crocodile of Huaxia medicine with total assets today.

Of course, the scale of China's pharmaceutical companies is far from being comparable with the pharmaceutical giants of the old capitalist countries in Europe and the United States. What is the United States, Pfizer, Germany, Bayer, etc., is by no means qualified for comparison among China's pharmaceutical companies at this stage, this is not arrogant, but has a profound historical reason, as a member of China. Yuan, the law deceives itself about this, and can only face up to the gap and redouble its efforts.

Jiang Tianyue and Xia Ye, the old classmates, had a very harmonious conversation with Ding Xiaoping and Lu Ming. Jiang Tianyue got on the line with Su Ning through some connections and invited Su Ning to join his Huaxia Club and serve as an executive member, originally Jiang Tianyue invited Su Ning to join the Huaxia Club, he didn't know the power behind Su Ning, he just regarded Su Ning as the representative of Xinlan Group in Huaxia, and he didn't know until later. It turned out that Su Ning's rise had a deeper background, and this background happened to coincide with his Jiang Tianyue's background, so he immediately recommended Su Ning to become the executive committee member of the Huaxia Society, so as to consolidate the cooperative relationship between the two sides.

As for Xia Ye, her relationship with Su Ning is a little more interesting. In order to create income and profits, Linjing Trust and Investment Company took a lot of steps to find an opportunity to invest in Tianxin Pharmaceutical Group, which was not short of funds, to acquire Linjing Pharmaceutical Group. In this process, of course, it is actually a win-win situation, after all, Tianxin is no longer short of money. It is always good to have an investment, and Linjing Trust and Investment Company has almost found an investment with a probability of nearly 100% success, and of course it is also very cost-effective. The only thing that is not counted is Linjing Pharmaceutical, because of the intervention of Linjing Trust Investment, the acquisition of Zhongtianxin Pharmaceutical Group is almost free of charge to use the government public relations capabilities of Linjing Trust. As a result, the purchase price was pressed again and again, and the final result was that after accepting the investment of Linjing Trust. The purchase price was reduced to about 70% of the original, and after removing the interest, Tianxin Group still made hundreds of millions. As a result of this acquisition, two parties to the three-way game made a lot of money, while the party that "sold out" made a huge loss.

Of course, this is only from the assets of the calculation, in fact, Linjing Pharmaceutical Group in the past ten years, year after year, when the restructuring of state-owned assets can not be carried out effectively, if not sold, the country is afraid of losing more, so even if it is sold at a low price, in a sense, it is actually not a loss, at least it is a big burden. In this game, the real loss is some of the original employees of Linjing Pharmaceutical Group, because after being acquired by Tianxin, Tianxin, as a private enterprise, will inevitably not allow so many ineffective human resources to exist, layoffs are 100% and ironclad, as for who to layoff, it is difficult to say. Anyway, how to solve this group of people, Tianxin will definitely not care, this is the government's business, let the government have a headache.

Ding Xiaoping could almost guess why he was invited over this time, and he knew it in his heart. Since it is Su Dong of Tianxin Pharmaceutical Group who appeared, let's talk today. , the point must be medicine, and he as a holding Qidong several donkey skins supply large-scale agricultural Canzhen Zuo Zong, naturally has a strong voice in some projects such as Ejiao. He was a little shocked in his heart, Tianxin Pharmaceutical Group had only annexed Linjing Pharmaceutical for less than half a year, could it be able to digest such a large enterprise. Then set his sights on Qidong Ejiao? It must be known that Qidong Ejiao's annual profit last year was not much worse than that of Tianxin Pharmaceutical Group, which did not acquire Linjing Pharmaceutical last year.

Of course, no matter what he thinks in his heart. Naturally, it is impossible to say this, and it is impossible to even show the slightest expression in his expression.

As for Lu Ming, he naturally knew the reason why he was invited to join today's meeting: he was engaged in the import and export business of medicinal materials, had deep connections in the party and government organs in Linjing, and had good import and export channels in South Korea, Japan, Taiwan and some countries in Southeast Asia. If there is anything else that Su Dong needs to cooperate with him, it is nothing more than this.

The conversation between the four of them continued, and today's protagonist Su Ning was still on the high highway from the capital to Linjing.

Su Ning's face is exceptionally good today, her skin is also extremely delicate, and there is a faint red tide on her pink neck that has not completely faded.

When talking to Xiao beside him, his eyes were also watery and clear.

After the two met, Xiao Du did not tell Su Ning about the danger of flood fighting and rescue and the high-intensity overdraft of the body, but Su Ning was a nurse, how could he not see the tanned Xiao Ke in front of him. In fact, she has already exhausted all her recent energy, and she has also learned some about the flood fighting and rescue situation in Langliu and even the entire Xiaonan from other channels, Mayor Xiao's activity report collection She did not miss it once, and appeared in different locations at different times for several days in a row, obviously Xiao Ke didn't sleep much at all.

Su Ning naturally didn't want to be intimate with Xiao Ding at such a time, and Xiao Ke didn't care about his body. She couldn't bear to see her lover so overdrawn. forcibly let Xiao Ding eat a supposedly tonic dinner at her and then go to sleep, and slept until the next afternoon, when she woke up naturally, Su Ning prepared dinner for Xiao Zhen, who was hungry. After the two finished eating, Xiao Ding, who had recovered his energy, naturally wanted to repay this well-behaved and considerate little woman, and after a fierce battle, Su Ning almost forgot about today's party.

But the strict working hours for a long time made Su Ning just confused for a while, and then remembered today's business, and after waking up Xiao Ke, the two of them came to drive to Linjing.

As always. Su Ning must tell Xiao Zhen about Tianxin's exhibition and planning. Although Xiao had already said that Su Ning would do these things by himself, Su Ning showed up. Xiao Ke's gaze was extremely precise, and he felt that he had wasted such a master strategist and prophet. That is almost a great irresponsibility to the Tianxin Group, so I insist on talking about it every time I meet with Xiao Xiao, and then listen to what Xiao Ding thinks about it.

"So my opinion is: China's current pharmaceutical manufacturing industry is very competitive on the one hand. On the other hand, due to the strong position of pharmaceutical manufacturers in the industrial chain, the industry is very attractive. The fact that there are many pharmaceutical manufacturers in the whole industry in China, but there are no listed companies with a market value of more than 100 billion yuan supports the first conclusion, and the characteristics of the overall high gross profit of the pharmaceutical industry support the second conclusion. Such a conclusion is easily reminiscent of the fact that there will be new entrants and exiters in this industry, but the strong position of pharmaceutical manufacturing enterprises in the entire industrial chain is difficult to shake. Looking closely, new entrants will encounter more and more barriers, including Xinding standards, pollution emission standards, brand awareness, etc., which have objectively raised the entry threshold, while the exit mechanism has not changed significantly, so the increase in industry concentration is predictable. So. I agree with the management of the group. We should take advantage of this opportunity to expand Hao Ermo as much as possible. Forming a stronger brand advantage You know, our Chinese people still believe in big enterprises, the bigger the more trustworthy, because there is an old saying, the monk can't run the temple, the bigger the enterprise, the more they can rest assured that Su Ning is now analyzing, and it is becoming more and more professional.

Xiao Zhen nodded lightly, thought for a while, and said, "In fact, the medical industry is simply divided into pharmaceutical manufacturing. There are four sub-sectors of pharmaceutical circulation, medical services, and medical device manufacturing. Due to the fact that Huaxia currently lacks listed companies in the medical service industry. And the reason why the pharmaceutical distribution industry is more similar to other distribution industries, and the medical device manufacturing industry is more similar to other manufacturing industries, so I have always advised you to focus mainly on the pharmaceutical manufacturing industry. As for this sub-industry, we can divide into APIs, chemical drugs, biological products and traditional Chinese medicine," Xiao Zhen said, paused slightly, thought for a while, and then continued: "I am not a medical expert. Therefore, it is impossible to make an accurate judgment on the comparative advantages and disadvantages of Huaxia in the above four sub-industries. But through what I know about some of the sources. Generally speaking, we know that the Chinese people do not have a comparative advantage in the first three sub-industries, in fact, the Chinese medicine industry is our strong industry, and it is the same as the liquor is a Chinese characteristic, although people are still disagreeable about whether Chinese medicine can successfully enter the world's mainstream drug market. Furthermore. Personally, I think that only in this sub-industry can we find companies with core competitiveness. I am more optimistic about the two types of traditional Chinese medicine companies, the model of Yunnan Baiyao, through the theft of the formula to obtain the heart of the mountain, plus cut into the field of daily consumer goods, through the characteristic curative effect to obtain differentiation, so as to effectively expand the company's own bottleneck. The second is the Tasly model. The post-advantage is obtained through the improvement of traditional Chinese medicine. By integrating into Western market standards, it is expected to enter the world's mainstream pharmaceutical market. Of course, this does not mean that these two companies have succeeded, and this needs to be further observed and explored. ”

"Wait." Su Ning frowned: "Do you think we can only have core competitiveness in traditional Chinese medicine?" ”

"This. Naturally, the statement is not absolute. But relatively speaking, I think it is. Xiao didn't see a hint of disbelief flashing in Su Ning's eyes, but he still smiled faintly and said, "Whether it's chemical drugs or biological products." It is a universal fact that Western countries are ahead of our curve. We have to catch up in these areas, but there is no denying it. It's going to be a process, and it's probably going to be a long-term process, during which we're at a disadvantage compared to these advanced Western technologies, can you agree? ”

Although Su Ning was a little unconvinced, she still nodded, but she said: "But we can increase investment in scientific research and increase the introduction of talents, so that we can definitely narrow the gap between us as quickly as possible."

"As fast as possible? Well, I agree, but how long? Three years, five years, is it possible? I don't think so, it's a systems science. The establishment and improvement of its knowledge system will not be something that we will be able to catch up with in a moment. I'm not pessimistic. It's just that we should try our best to take advantage of our traditional Chinese medicine and make our traditional Chinese medicine advantages bigger and stronger. Xiao Ke said.

"Yunnan Baiyao is the dominant enterprise you are talking about? But why do I feel that Yunnan Baiyao is a little unenterprising, Su Ning frowned.

Xiao Zhen laughed and said, "More than four years ago. Qu Lianzhang created "Baibaodan, which laid the foundation of today's Yunnan Baiyao. Until today, Yunnan Baiyao still maintains its vigorous vitality and unique characteristics, and has successfully entered the daily chemical industry with its unique curative effect, and Yunnan Baiyao toothpaste has been able to sell for 3,400 million, and it is almost impossible to say that Baiyao will lose its vitality. In fact, there are two best things about Baiyao: one is its excellent efficacy in the field of hemostasis; The second is its irreproducibility. Xiao Ding picked up the water cup from under the center console and took a sip, and continued: "Baiyao is the country's two. One of the top-secret protected varieties of traditional Chinese medicine is the holy medicine of wounds. Different from the average pharmaceutical stock. There is no need to rely on continuous research and innovation to gain the momentum to move forward. Baiyao relies on the formula to maintain its irreproducibility and expand the market by relying on efficacy. Like you, many people criticize Baiyao for not being technologically aggressive. But in my opinion, this is actually an unreasonable view. Can we ask Coca-Cola and Moutai to keep innovating? Improve Coca-Cola into delicious soy sauce or change Moutai into a shield? This is suicide. Contrary to the conventional wisdom, I believe that it is almost the highest level for companies to gain a monopoly position by relying on formula and efficacy, which is far more clever than relying on R&D investment to promote the sales of patented products and gain market share. Because the latter comes with high costs, while the former does not. In fact, the pricing power of Baiyao in pharmaceutical stocks is very strong, in addition. Considering the various dosage forms of baiyao and baiyao derivatives such as toothpaste, then baiyao is actually the single-variety sales champion in China. The greatest contribution of the management of Baiyao to Baiyao is that it is leading Baiyao to the field of daily chemicals. And trying to be in a.... The Xinbei niche market has found its place. The significance of this move is also that the exhibition space of Baiyao has been greatly activated. Originally, the space of Baiyao in the field of traumatology can still be expanded, and other indications of Baiyao have yet to be explored, and there are many cases of Baiyao treating hemorrhoids, frostbite, postpartum hemorrhage and a large number of diseases in my family's Baiyao manual, and now Baiyao can also be made into toothpaste and other derivatives, which greatly enriches the connotation and market of Baiyao. In addition, there is almost no overseas search field. In the future, the internationalization of Baiyao should be based on curative effects. The identity of the brand, the general health care product is widely known to the world. Of course, it is almost impossible for Baiyao to enter the global mainstream pharmaceutical market as a drug, due to top-secret formulations and the conflict between Western drug access rules and traditional Chinese patent medicines. But I don't think that's the biggest problem, I always stick to the point I mentioned at the beginning of Tianxin Pharmaceutical Group's business, pharmaceutical companies are different from others. It is related to the life and health of the people, and while we consider making a profit, we must also give full consideration to the price and efficacy of medicines. It's still the old saying: "Medical skills are benevolent skills, and the heart of heaven is my heart." I hope that one day, Tianxin will be the common heart of the 1.3 billion people in China. ”

Su Ning didn't speak, first, she couldn't deny the efficacy of Yunnan Baiyao, it was indeed the No. 1 medicine in China, its efficacy was significant, and the range of action was not comparable to other drugs. The second is the price, it should be said that it is relatively popular, at least much cheaper than Western medicine, and many Western medicine can not solve or spend a lot of money to solve the problem, dozens of yuan of white medicine can be easily done, according to Xiao Ding's "the ultimate purpose of the pharmaceutical industry is to repay the society" this concept. It is not difficult to see the reason why he admires white medicine so much.

"White medicine, white medicine." Su Ning read softly, her mind no longer knowing where to fly.

Yi Xunshu is a different body clam